Our industry is focused on finding ways to help expand and direct the power of human immunity against diseases in new and powerful ways. We believe that the key to doing this lies not in over-engineering biological responses or chemical reactions in vivo. After all, we are already hard-wired with an elegant, powerful way to combat serious diseases.
And the power of our approach starts with our groundbreaking delivery formulation that we believe will provide a powerful mechanism to present stimulants to the human immune system, and sustain them over time. Our platform utilizes a proprietary, extraordinarily stable “NO-RELEASE” delivery system that is 100 percent oil-based, which mitigates the propensity for synthetic peptides or antigens to break down, thereby extending the stimulation of the immune response.
Our formulations promote the uptake and extended delivery to cells of the immune system, thereby producing a more rapid, robust and sustained immune response against specific disease targets. Each formulation is comprised of one or more immunologic agents, usually an antigen and an adjuvant, encapsulated in nanoscale lipid particles. Following administration, our formulation does not release components at the injection site, allowing it to continuously interact with and stimulate the immune system over an extended period of time.
To date, our candidate products have been successfully tested in hundreds of human subjects across multiple indications.
Working at IMV brings you to the forefront of cutting-edge science and research for cancer and other serious diseases. We’ve worked hard to build a culture of innovation and collaboration.Learn more about life at IMV